Medidata Recognized as a Leader in Everest Group’s Inaugural Electronic Data Capture PEAK Matrix® Assessment
17 Settembre 2024 - 2:00PM
Business Wire
Medidata, a Dassault Systèmes brand and the leading provider of
clinical trial solutions to the life sciences industry, has been
recognized as a Leader in Everest Group‘s first-ever PEAK Matrix®
Assessment for Electronic Data Capture (EDC) in life sciences.
The report, which evaluated 20 providers, highlighted Medidata
Rave EDC for its seamless integration with wearables, sensors, and
EHRs, along with its advanced capabilities in source data
verification, AI-driven query management, and adverse event
handling. Rave EDC earned recognition for its intuitive, low-code
design, enabling rapid implementation of protocol amendments, and
simplifying the creation of electronic case report forms (eCRFs),
while maintaining data quality and integrity for clinical trial
sponsors.
“We are honored to be recognized as a Leader in EDC by Everest
Group,” said Anthony Costello, CEO, Medidata. “Rave EDC, the
industry gold standard, has led electronic data capture for
decades. Given the constantly evolving healthcare landscape, we
continue to innovate to meet the growing demands for decentralized
trials, empowering sponsors to use real-time data and AI to drive
innovation and efficiency in the development of life-saving
treatments.”
The Everest Group report emphasized Medidata’s strong brand
presence among large and mid-sized pharmaceutical companies and its
extensive partnerships with CROs and clinical trial technology
providers. This recognition reinforces Medidata’s leadership in
driving the future of digital clinical trials.
For more information, visit our website.
About Medidata
Medidata is powering smarter treatments and healthier people
through digital solutions to support clinical trials. Celebrating
25 years of ground-breaking technological innovation across more
than 34,000 trials and 10 million patients, Medidata offers
industry-leading expertise, analytics-powered insights, and the
largest patient-level historical clinical trial data set in the
world. More than 1 million registered users across approximately
2,200 customers trust Medidata’s seamless, end-to-end platform to
improve patient experiences, accelerate clinical breakthroughs, and
bring therapies to market faster. A Dassault Systèmes brand
(Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered
in New York City and has been recognized as a Leader by Everest
Group and IDC. Discover more at www.medidata.com and follow us
@Medidata.
About Dassault Systèmes
Dassault Systèmes is a catalyst for human progress. We provide
business and people with collaborative virtual environments to
imagine sustainable innovations. By creating virtual twin
experiences of the real world with our 3DEXPERIENCE platform and
applications, our customers can redefine the creation, production
and life-cycle-management processes of their offer and thus have a
meaningful impact to make the world more sustainable. The beauty of
the Experience Economy is that it is a human-centered economy for
the benefit of all –consumers, patients and citizens. Dassault
Systèmes brings value to more than 350,000 customers of all sizes,
in all industries, in more than 150 countries. For more
information, visit www.3ds.com.
© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS
logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA,
CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE,
SIMULIA and SOLIDWORKS are commercial trademarks or registered
trademarks of Dassault Systèmes, a European company (Societas
Europaea) incorporated under French law, and registered with the
Versailles trade and companies registry under number 322 306 440,
or its subsidiaries in the United States and/or other countries.
All other trademarks are owned by their respective owners. Use of
any Dassault Systèmes or its subsidiaries trademarks is subject to
their express written approval.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240917798345/en/
Medidata PR Medidata.PR@3ds.com
Analyst Relations medidata.AR@3ds.com
Grafico Azioni Big Tree Cloud (NASDAQ:DSY)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Big Tree Cloud (NASDAQ:DSY)
Storico
Da Nov 2023 a Nov 2024
